Severe Asthma Research Program - University of Virginia (SARP3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01761058

Recruitment Status : Unknown

Verified July 2013 by University of Virginia.
Recruitment status was: Recruiting

First Posted : January 4, 2013

Last Update Posted : July 2, 2013

Sponsor:

Collaborators:

National Heart, Lung, and Blood Institute (NHLBI)

Case Western Reserve University

Information provided by (Responsible Party):

University of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	January 2017
Estimated Study Completion Date :	May 2017

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, Raymond WW, Lachowicz-Scroggins ME, Di Maio S, Hoffman EA, Castro M, Fain SB, Jarjour NN, Israel E, Levy BD, Erzurum SC, Wenzel SE, Meyers DA, Bleecker ER, Phillips BR, Mauger DT, Gordon ED, Woodruff PG, Peters MC, Fahy JV; National Heart Lung and Blood Institute (NHLBI) Severe Asthma Research Program (SARP). Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018 Mar 1;128(3):997-1009. doi: 10.1172/JCI95693. Epub 2018 Feb 5.

To Top